glp-1 obesity drug news today october 16 2025 Alarming rise in weight loss overdoses GLP-1 Agonists Weight Loss Drugs
Description
Cardiovascular disease is another major driver
A new review explores how GLP-1 receptor agonists may blunt alcohol and drug reward signals, opening a promising but still unproven path toward repurposed treatments for addiction
Seong JM, Yee J, Gwak HS
It can be taken at any time of day, with or without food, and with any volume of fluid
Real life lets you keep the safety net
Item 2657277 Gently remove the patch from its backing and place it on a clean, hair-free area of your skin
